Mumbai has emerged as a significant hub for pharmaceutical manufacturing , with several companies specializing in the development of Active Pharmaceutical Ingredients (APIs). Notably, a number of key firms are focused on the production of Finasteride API (CAS No: 98319-26-7), meeting the global demand for this crucial ingredient. These factories of